Gold Member Since 2016
Shenzhen Sendi Biotechnology Co., Ltd.

Etoricoxib Buy, Etoricoxib Supplier, Etoricoxib for Sale manufacturer / supplier in China, offering Etoricoxib Powder CAS202409-33-4 Pharmaceutical Raw Materials, Diflorasone (ointment) C22h28f2o5 Apexicon Anti-Inflammatory Glucocorticoids, Bodybuilding Supplement Androgenic Steroids Mibolerone Acetate CAS 3704-09-4 and so on.

(/ )

Supplier Homepage Product Pharmaceutical and Medical Others Pharmaceutical and Medical Etoricoxib Powder CAS202409-33-4 Pharmaceutical Raw Materials

Etoricoxib Powder CAS202409-33-4 Pharmaceutical Raw Materials

Purchase Qty.:
(grams)
10-49 50-99 100+
FOB Unit Price: US $5 US $2.5 US $1
Purchase Qty. (grams) FOB Unit Price
10-49 US $5
50-99 US $2.5
100+ US $1
Get Latest Price
Port: Shanghai, China
Production Capacity: 100kgs/Week
Payment Terms: T/T, Western Union, Paypal, Money Gram, BITCION

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: 315-37-7
  • Customized: Non-Customized
  • Suitable for: Adult
  • Purity: >99%
  • Quality Standard: USP
  • Transportation: DHL, UPS, TNT, EMS, FedEx or Other
  • Transport Package: 1kg/Bag, 100grams/Bag, 10grams/Bag
  • Origin: China
  • Powder: Yes
  • Certification: GMP, ISO 9001, Ep5
  • State: Solid
  • Appearance: White Powder
  • MOQ: 10g
  • Trademark: Sendi
  • Specification: 1kg/bag, 100grams/bag, 10grams/bag
  • HS Code: 3001200010
Product Description
what is Etoricoxib
Etoricoxib (Arcoxia) is a selective COX-2 inhibitor from Merck & Co. Currently it is approved in more than 80 countries worldwide but not in the US, where the Food and Drug Administration (FDA) has required additional safety and efficacy data for etoricoxib before it will issue approval.


Etoricoxib COA
ItemsStandardsResults
AppearanceWhite to 0ff-white powder
0ff-white powder
 

Residue on Ignition
 
≤0.1%0.074%
Related substances
 
Single biggest impurity≤0.1%
 
Total impurities≤0.5%
 
0.01%
 
0.04%
 
Assay(HPLC) 
≥98%
 
99.9%

Etoricoxib is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain, and gout. Approved indications differ by country .

A Cochrane systematic review assessed the benefits of single-dose etoricoxib in reduction of acute post-operative pain in adults. Single-dose oral etoricoxib provides good quality pain relief post-operatively in adults and adverse events are similar to placebo in the studies included. Etoricoxib given at a dose of 120 mg is as effective or even better than other analgesics that are commonly used .
 
Send your message to this supplier
Avatar
Miss Cherry Whatsapp:+8618126147481
*From:
To: Miss Cherry Whatsapp:+8618126147481
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category